Problems Arising from the Generalising of Treatment Efficacy from Clinical Trials in Alzheimer's Disease: Mistaking Statistical Significance as Clinical Significance

Author： Becker R.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.19, Iss.1, 2000-01, pp. : 33-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Memantine for the Treatment of Alzheimer's Disease: Tolerability and Safety Data from Clinical Trials

By Farlow Martin R.  

Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. : 577-585

Adis International

Access to resources Recommend Favorite

Polyphenols from Red Wine Modulate Immune Responsiveness: Biological and Clinical Significance

By  

Current Pharmaceutical Design, Vol. 14, Iss. 26, 2008-09 ,pp. : 2733-2748

Bentham Science Publishers

Access to resources Recommend Favorite

Phytochemicals in Alzheimer Disease: The Development of Clinical Trials

By Quinn Joseph   Kaye Jeffrey   Montine Thomas   Stackman Robert  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 42, Iss. 1, 2004-01 ,pp. : 64-73

Informa Healthcare

Access to resources Recommend Favorite

From Preclinical to Clinical Trials: An Update on Potential Therapies for Huntington’s Disease

By S. Brocardo Patricia   M. Gil-Mohapel Joana  

Current Psychopharmacology, Vol. 2, Iss. 2, 2013-05 ,pp. : 113-131

Bentham Science Publishers

Access to resources Recommend Favorite

Lessons to Learn from Crohn's Disease Clinical Trials: Implications for Ulcerative Colitis

By  

Current Drug Targets, Vol. 12, Iss. 10, 2011-09 ,pp. : 1467-1477

Bentham Science Publishers

Access to resources Recommend Favorite